Uncertainty lingers for many federally-funded climate, energy and environment projects in Massachusetts, as President Trump ...

The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...

IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...

Donald Trump is withholding of federal funds from Joe Biden's Inflation Reduction Act even though his oil and gas donors have ...

The Inflation Reduction Act (IRA) significantly changed the popular Medicare drug programs. While an IRA policy goal is to reduce the ...

Trump rescinded Executive Order 14087, "Lowering Prescription Drug Costs for Americans," which directed Medicare and Medicaid ...

Mark Zuckerberg wore a highly exclusive watch in a video announcement on Tuesday. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...

"Biden inherited an economy that was flat on its back because of the pandemic, and he's bequeathing an economy that's flying high," said Mark Zandi, chief economist at Moody's Analytics. "Having said ...

The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.

The negotiations will occur this year and any negotiated prices will become effective in 2027, according to a Centers for Medicare & Medicaid Services fact ... the Inflation Reduction Act, and ...

made possible through the Inflation Reduction Act (IRA). Drug manufacturers will have until Feb. 28 to opt in to, or out of, negotiations with the federal government, which are expected to ...